MedPath

The association between the neutralizing activity and the amount of antibody in early stages of SARS-CoV-2 infection: A multicenter observational study

Not Applicable
Conditions
COVID-19 (SARS-CoV-2 infection)
Registration Number
JPRN-UMIN000040931
Lead Sponsor
Yokohama City University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

<A prospective observational study> Patients who meet the following criteria are excluded (1) Patients with mental illness or other conditions that are believed to affect their ability to consent. (2) Other patients who are deemed by the researcher to be unsuitable to participate in the research. <A retrospective observational study> There are no exclusion criteria.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath